{"entity":{"type":"insider","cik":"0001889334","url":"/insider/0001889334","json_url":"/insider/0001889334.json","name":"Rachman Ilya M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":8,"first":"2021-12-20","last":"2025-12-10","span_basis":"filed_date"},"name_variants":[{"name":"Rachman Ilya M","source":"filing","n_filings":8,"first_seen":"2021-12-20","last_seen":"2025-12-10"}],"transactions":[{"id":4926024,"accession":"0001493152-25-027109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-027109","line_url":"/filing/0001493152-25-027109#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":746.0,"shares_display":"746","price_per_share":6.67,"price_display":"6.67","price_state":"stated","total_value":4975.82,"total_display":"4,975.82","shares_owned_after":1141683.0,"shares_owned_after_display":"1,141,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-10","scope":"insider"},{"id":4925853,"accession":"0001493152-25-013919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-013919","line_url":"/filing/0001493152-25-013919#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","shares_owned_after":1140937.0,"shares_owned_after_display":"1,140,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-17","scope":"insider"},{"id":4996546,"accession":"0001641172-25-015756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-015756","line_url":"/filing/0001641172-25-015756#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2178.0,"shares_display":"2,178","price_per_share":2.295,"price_display":"2.30","price_state":"stated","total_value":4998.51,"total_display":"4,998.51","shares_owned_after":1138437.0,"shares_owned_after_display":"1,138,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":2316701,"accession":"0001493152-24-023287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-023287","line_url":"/filing/0001493152-24-023287#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2600.0,"shares_display":"2,600","price_per_share":2.13,"price_display":"2.13","price_state":"stated","total_value":5538.0,"total_display":"5,538.00","shares_owned_after":1136259.0,"shares_owned_after_display":"1,136,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-10","scope":"insider"},{"id":2112350,"accession":"0001493152-24-022653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-022653","line_url":"/filing/0001493152-24-022653#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3300.0,"shares_display":"3,300","price_per_share":1.8091,"price_display":"1.81","price_state":"stated","total_value":5970.03,"total_display":"5,970.03","shares_owned_after":1133659.0,"shares_owned_after_display":"1,133,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-05","scope":"insider"},{"id":3256464,"accession":"0001493152-24-019366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-019366","line_url":"/filing/0001493152-24-019366#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4300.0,"shares_display":"4,300","price_per_share":2.2465,"price_display":"2.25","price_state":"stated","total_value":9659.95,"total_display":"9,659.95","shares_owned_after":912000.0,"shares_owned_after_display":"912,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-14","scope":"insider"},{"id":6936453,"accession":"0001493152-22-032557","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-22-032557","line_url":"/filing/0001493152-22-032557#line-3","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4050.0,"shares_display":"4,050","price_per_share":1.019,"price_display":"1.02","price_state":"stated","total_value":4126.95,"total_display":"4,126.95","shares_owned_after":906550.0,"shares_owned_after_display":"906,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-15","scope":"insider"},{"id":6936450,"accession":"0001493152-22-032557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-032557","line_url":"/filing/0001493152-22-032557#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":950.0,"total_display":"950.00","shares_owned_after":907550.0,"shares_owned_after_display":"907,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-15","scope":"insider"},{"id":6936447,"accession":"0001493152-22-032557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-032557","line_url":"/filing/0001493152-22-032557#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":148.5,"total_display":"148.50","shares_owned_after":907700.0,"shares_owned_after_display":"907,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-15","scope":"insider"},{"id":4478250,"accession":"0001493152-21-032038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-032038","line_url":"/filing/0001493152-21-032038#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889334","owner_name":"Rachman Ilya M","owner_url":"/insider/0001889334","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","shares_owned_after":902500.0,"shares_owned_after_display":"902,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001873835","name":"Immix Biopharma, Inc.","url":"/issuer/0001873835","role":"Director, Officer (CEO and Chairman)","n_filings":8,"first_seen":"2021-12-20","last_seen":"2025-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001889334","retrieved_at":"2026-08-21T11:06:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}